Inloggad som:

DALIA

Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.

DALIA
A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF ABP 959 COMPARED WITH ECULIZUMAB IN ADULT SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF ABP 959 COMPARED WITH ECULIZUMAB IN ADULT SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
PLACEHOLDER
Mer information om studien för vårdgivare
Behandling
Fas 3
Kurativ
Företag

Studien ändrades senast av: studyjohanna (2020-08-25)

Tillbaka till listan